Multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit

Journal of Chemotherapy

Volumn 20, Issue 2, 2008, Pages 219-224

  Orsi, G B ^a   Franchi, C ^b   Giordano, A ^a   Rocco, M ^b   Ferraro, F ^a   Mancini, C ^a   Venditti, M ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Acinetobacter baumannii; Colistin; Cross infection; Drug resistance; Intensive care unit; Outbreak; Tigecycline

Indexed keywords

COLISTIN; GENTAMICIN; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CLINICAL ARTICLE; CROSS INFECTION; DISEASE CARRIER; EPIDEMIC; FEMALE; HUMAN; INFECTION CONTROL; INTENSIVE CARE; INTENSIVE CARE UNIT; ITALY; MALE; MOLECULAR TYPING; MORTALITY; MULTIDRUG RESISTANCE; RANDOM AMPLIFIED POLYMORPHIC DNA;

EID: 44849121737     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.2.219     Document Type: Article

References (19)

1. Denton M, Wilcox MH, Parnell P et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 2004, 56: 106-110.
2. Carbonne A, Naas T, Blanckaert K et al. Investigation of a nosocomial outbreak of extended-spectrum B-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect 2005, 60: 14-18.
3. Fierobe L, Lucet JC, Deere D et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 2001, 22: 35-40.
4. Ling ML, Ang A, Wee M, Wang GC. A nosocomial outbreak of multiresistant Acinetobacter baumannii originating from an intensive care unit. Infect Control Hosp Epidemiol 2001, 22: 48-49.
5. Villegas MV, Hartstein AL. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003, 24: 284-295.
6. Wang SH, Sheng WH, Chang YY et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J Hosp Infect 2003, 53: 97-102.
7. Wilks M, Wilson A, Warwick S et al. Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation. Infect Control Hosp Epidemiol 2006, 27: 654-658.
8. Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2006, 43 (Suppl 2): S100-105.
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. (1996) CDC definitions for nosocomial infections. In APIC Infection Control and Applied Epidemiology: Principles and Practice. Mosby, St Louis; 1993: pp A-1-A-20.
10. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: performance standards for antimicrobial disk susceptibility tests, Approved standard 2003, 6th ed. M7-A6. NCCLS, Wayne, Pa.
11. Carr E, Eason H, Feng S et al. RAPD-PCR typing of Acinetobacter isolates from activated sludge systems designed to remove phosphorus microbiologically. J Appl Microbiol 2001, 90: 309-319.
12. Struelens MJ, Schwam V, Deplano A, Baran D. Genome macrorestriction analysis of diversity and variability of P. aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol 1993, 31: 2320-2326.
13. Garner JS. The Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996, 17: 53-80.
14. Levesque C, Piche L, Larose L, Roy PH. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 1995, 39: 185-191.
15. Zarrilli R, Crispino M, Bagattini M et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004, 42: 946-953.
16. Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect 2002, 8: 144-153.
17. Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and casecontrol studies. Crit Care 2006, 10 (2): R48.
18. Petrosillo N, Chinelli P, Proietti MF et al. Combined Colistin and rifampacin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin Microbiol Infect 2005; 11 (8): 682-683.
19. Pankey GA. Tigecycline. J Antimicrob Chemother 2005; 56, 470-480.